ABC | Volume 111, Nº6, December 2018

Short Editorial Antoniazzi Can non-pharmacological treatment promote additional benefit for children with FH treated with statins? Arq Bras Cardiol. 2018; 111(6):822-823 1. Santos RD, Gagliardi AC, Xavier HT, Casella Filho A, Araújo DB, Cesena FY, et al. First Brazilian Guidelines for Familial Hypercholesterolemia. Arq Bras Cardiol. 2012;99(2 Suppl 2):1-28. 2. RaderDJ,CohenJ,HobbsHH.Monogenichypercholesterolemia:newinsights in pathogenesis and treatment. J Clin Invest. 2003;111(12):1795-803. 3. Leren TP. Cascade genetic screening for familial hypercholesterolemia. Clin Genet. 2004;66(6):483-7. 4. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronaryheartdisease:consensusstatementoftheEuropeanAtherosclerosis Society. Eur Heart J. 2013;34(45):3478-90a. 5. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J Clin Lipidol. 2014;8(2):148-72. 6. Daniels SR, Gidding SS, de Ferranti SD; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(3 Suppl):S30-7. 7. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2010;7(7):CD006401. 8. Radaelli G, SausenG, Cesa CC, Santos FS, Portal VL, Neyeloff JL, et al. Statin treatments and dosages in children with familial hypercholesterolemia: meta-analysis. Arq Bras Cardiol. 2018; 111(6):810-821. 9. Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2000;4(29):1-123. 10. Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al. Familial Hypercholesterolemia: Screening, diagnosis andmanagement of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(3 Suppl):S1-8. 11. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(3 Suppl):S9-17. 12. McCrindle BW. Familial hypercholesterolemia in children and adolescents. Curr Opin Lipidol. 2012;23(6):525-31. 13. Shafiq N, Singh M, Kaur S, Khosla P, Malhotra S. Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst Rev. 2010;20(1):CD001918. 14. Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJ, Stroes ES. Plant sterols lowerLDLcholesterolwithout improvingendothelial function inprepubertal children with familial hypercholesterolaemia. J. Inherit. Metab Dis. 2003;26(4):343-51. 15. Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterstøl K, et al. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia. Atherosclerosis. 2016;252:21-7. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 823